Kenvue Names Jon Halvorson CMO Amid Tylenol Autism Controversy and Kimberly-Clark Merger
- Nov, 4 2025
- 0
Kenvue appointed Jon Halvorson as CMO amid Tylenol autism allegations and a pending merger with Kimberly-Clark, as sales declined and legal pressure mounted. The move aims to rebuild trust through AI-driven digital marketing.